SKI Market

Indian Indices

Sensex

82,814.71 316.57
( 0.38%)

Global Indices

Nasdaq

49,649.56 233.39
(0.47%)

Dow Jones

6,930.29 47.40
(0.69%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,691.66 64.62
(0.61%)

Forex

USD-INR

91.03 0.34
(0.37%)

EUR-INR

107.23 0.00
(0.00%)

GBP-INR

122.67 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5573934

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

23.03

106859.35

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.62

Back

ridhi synthetics ltd

Indo National consolidated net profit declines 47.93% in the September 2025 quarter

Oct 29,2025

Net profit of Indo National declined 47.93% to Rs 1.13 crore in the quarter ended September 2025 as against Rs 2.17 crore during the previous quarter ended September 2024. Sales declined 6.25% to Rs 119.60 crore in the quarter ended September 2025 as against Rs 127.57 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	119.60	127.57	-6
OPM %	3.31	0.70	-
PBDT	4.80	4.74	1
PBT	1.50	1.88	-20
NP	1.13	2.17	-48

82,814.71 316.57 ( 0.38%)

49,649.56 233.39 (0.47%)

6,930.29 47.40 (0.69%)

56,838.27 -629.56 (-1.10%)

10,691.66 64.62 (0.61%)

91.03 0.34 (0.37%)

107.23 0.00 (0.00%)

122.67 -0.16 (-0.13%)

0.59 0.00 (-0.25%)